繁體中文
简体中文
English
HOME
BIOFIRST
Profile and History
Management Team
Business Model
Mission Statement
Awards and Certification
DEVICE
Vitreous Substitute
Corneal preservation solution
Ocular Lrrigation Sloution
NANO-TECH
Nanomagnetic Drug Carrier
PRODUCTS
FiobroTest
Clover A1cTM Self
GlukoPet A1c
PARTNER
Taiwan
Overseas
NEWS
Latest News
Press Release
CONTACT
INVESTORS
匯特 贊助2015年血液腫瘤國際研討會
2015-09-01
匯特生技「眼科手術沖洗液」再獲日本專利
2015-08-03
BioFirst captures 25-billion future business opportunities with its liver fibrosis diagnosis system.
2014-08-20
Ophthalmic Fluid of BioFirst obtains Canadian patent. (August 07, 2014)
2014-08-07
phthalmic Fluid of OBioFirst obtains Canadian patent.
2014-08-07
BioFirst got license and patent. Stock raised 13 dollars in three days
2014-07-30
《GreTai》BioFirst Vitreous Substitute obtained invention patent in Korea.
2014-07-29
BioFirst’s “Artificial Vitreous” received recognition from European ophthalmic pharmaceuticals with MOU signed.
2014-07-28
Page 1 of 2
Start
Prev
1
2
Next
End
©2025 滙特生物科技股份有限公司 |
Designed by Hurricane Med
i
a